BLM is the product of the Blooms syndrome gene and belongs to the RecQ family of DNA helicases. BLM is associated with an increase in the incidence of many types of cancer at an early age.
| Inventor | Institute |
|---|---|
| Helen Turley | University of Oxford |
| Cat. #: | 151267 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Genetics |
| Application: | WB ; ELISA ; IHC ; IF ; WB |
| Target: | Bloom's Syndrome Protein (BLM) |
| Reactivity: | Human |
| Clone: | BFL 103 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | BLM is the product of the Blooms syndrome gene and belongs to the RecQ family of DNA helicases. BLM is associated with an increase in the incidence of many types of cancer at an early age. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Immunogen: | Recombinant Full Length Bloom's Protein |
| Myeloma used: | P3/NS1/1-Ag4.1 |
| Target background: | BLM is the product of the Blooms syndrome gene and belongs to the RecQ family of DNA helicases. BLM is associated with an increase in the incidence of many types of cancer at an early age. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.9 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Chen et al. 2019. Mol Med Rep. 19(6):4819-4831. PMID: 30957187. Zhu et al. 2008. J Biol Chem. 283(43):29405-15. PMID: 18708356. Small ubiquitin-related modifier (SUMO) binding determines substrate recognition and paralog-selective SUMO modification. Turley et al. 2001. Br J Cancer. 85(2):261-5. PMID: 11461087. The distribution and expression of the Bloom's syndrome gene product in normal and neoplastic human cells. Wu et al. 2000. J Biol Chem. 275(13):9636-44. PMID: 10734115. The Bloom's syndrome gene product interacts with topoisomerase III. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151025 | Anti-Vascular endothelium [10] |
Key Info
Anti-Vascular endothelium [10]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151033 | Anti-HSVUL42 [13C9] |
Key Info
Anti-HSVUL42 [13C9]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.